BriaCell Therapeutics (BCTX) Stock Climbs On Data Presentation

BriaCell Therapeutics BCTX Stock News

BriaCell Therapeutics Corp (NASDAQ: BCTX) is rocketing in the premarket hours this morning, and for good reason. The company, specializing in targeted immunotherapies for advanced breast cancer, announced positive clinical results.  Here’s the scoop: BriaCell Therapeutics Announces Positive Data As mentioned above, BriaCell Therapeutics is making its way for the top after announcing positive clinical … Read more